Annual CFO
-$778.78 M
-$2.44 B-146.82%
December 31, 2023
Summary
- As of February 22, 2025, VIR annual cash flow from operations is -$778.78 million, with the most recent change of -$2.44 billion (-146.82%) on December 31, 2023.
- During the last 3 years, VIR annual CFO has fallen by -$587.84 million (-307.87%).
- VIR annual CFO is now -146.82% below its all-time high of $1.66 billion, reached on December 31, 2022.
Performance
VIR Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$171.48 M
-$93.63 M-120.28%
September 30, 2024
Summary
- As of February 22, 2025, VIR quarterly cash flow from operations is -$171.48 million, with the most recent change of -$93.63 million (-120.28%) on September 30, 2024.
- Over the past year, VIR quarterly CFO has dropped by -$93.63 million (-120.28%).
- VIR quarterly CFO is now -117.86% below its all-time high of $960.14 million, reached on June 30, 2022.
Performance
VIR Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$466.64 M
-$15.65 M-3.47%
September 30, 2024
Summary
- As of February 22, 2025, VIR TTM cash flow from operations is -$466.64 million, with the most recent change of -$15.65 million (-3.47%) on September 30, 2024.
- Over the past year, VIR TTM CFO has dropped by -$15.65 million (-3.47%).
- VIR TTM CFO is now -128.06% below its all-time high of $1.66 billion, reached on December 31, 2022.
Performance
VIR TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
VIR Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -146.8% | -120.3% | -3.5% |
| 3 y3 years | -307.9% | -36.3% | -147.3% |
| 5 y5 years | -727.6% | -36.3% | -147.3% |
VIR Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -146.8% | at low | -117.9% | +56.0% | -128.1% | +40.1% |
| 5 y | 5-year | -146.8% | at low | -117.9% | +56.0% | -128.1% | +40.1% |
| alltime | all time | -146.8% | at low | -117.9% | +56.0% | -128.1% | +40.1% |
Vir Biotechnology Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$171.48 M(+120.3%) | -$466.64 M(+3.5%) |
| Jun 2024 | - | -$77.85 M(-28.8%) | -$450.99 M(-40.8%) |
| Mar 2024 | - | -$109.39 M(+1.4%) | -$762.39 M(-2.1%) |
| Dec 2023 | -$778.78 M(-146.8%) | -$107.93 M(-30.7%) | -$778.78 M(+22.5%) |
| Sep 2023 | - | -$155.83 M(-60.0%) | -$635.73 M(+75.6%) |
| Jun 2023 | - | -$389.25 M(+209.5%) | -$362.00 M(-136.7%) |
| Mar 2023 | - | -$125.78 M(-458.1%) | $987.38 M(-40.6%) |
| Dec 2022 | $1.66 B(-3595.0%) | $35.13 M(-70.2%) | $1.66 B(+1.7%) |
| Sep 2022 | - | $117.90 M(-87.7%) | $1.64 B(+15.8%) |
| Jun 2022 | - | $960.14 M(+74.5%) | $1.41 B(+138.5%) |
| Mar 2022 | - | $550.09 M(+7048.7%) | $592.03 M(-1344.0%) |
| Dec 2021 | -$47.59 M | $7.70 M(-107.3%) | -$47.59 M(-65.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$105.81 M(-175.5%) | -$137.34 M(+68.8%) |
| Jun 2021 | - | $140.06 M(-256.4%) | -$81.36 M(-64.9%) |
| Mar 2021 | - | -$89.53 M(+9.1%) | -$232.06 M(+21.5%) |
| Dec 2020 | -$190.94 M(+47.3%) | -$82.05 M(+64.6%) | -$190.94 M(+29.2%) |
| Sep 2020 | - | -$49.84 M(+368.5%) | -$147.77 M(+9.6%) |
| Jun 2020 | - | -$10.64 M(-78.0%) | -$134.89 M(-9.2%) |
| Mar 2020 | - | -$48.41 M(+24.5%) | -$148.55 M(+14.6%) |
| Dec 2019 | -$129.63 M(+37.8%) | -$38.88 M(+5.2%) | -$129.63 M(+42.8%) |
| Sep 2019 | - | -$36.95 M(+52.1%) | -$90.75 M(+68.7%) |
| Jun 2019 | - | -$24.30 M(-17.6%) | -$53.79 M(+82.4%) |
| Mar 2019 | - | -$29.49 M | -$29.49 M |
| Dec 2018 | -$94.10 M(+41.8%) | - | - |
| Dec 2017 | -$66.38 M | - | - |
FAQ
- What is Vir Biotechnology annual cash flow from operations?
- What is the all time high annual CFO for Vir Biotechnology?
- What is Vir Biotechnology annual CFO year-on-year change?
- What is Vir Biotechnology quarterly cash flow from operations?
- What is the all time high quarterly CFO for Vir Biotechnology?
- What is Vir Biotechnology quarterly CFO year-on-year change?
- What is Vir Biotechnology TTM cash flow from operations?
- What is the all time high TTM CFO for Vir Biotechnology?
- What is Vir Biotechnology TTM CFO year-on-year change?
What is Vir Biotechnology annual cash flow from operations?
The current annual CFO of VIR is -$778.78 M
What is the all time high annual CFO for Vir Biotechnology?
Vir Biotechnology all-time high annual cash flow from operations is $1.66 B
What is Vir Biotechnology annual CFO year-on-year change?
Over the past year, VIR annual cash flow from operations has changed by -$2.44 B (-146.82%)
What is Vir Biotechnology quarterly cash flow from operations?
The current quarterly CFO of VIR is -$171.48 M
What is the all time high quarterly CFO for Vir Biotechnology?
Vir Biotechnology all-time high quarterly cash flow from operations is $960.14 M
What is Vir Biotechnology quarterly CFO year-on-year change?
Over the past year, VIR quarterly cash flow from operations has changed by -$93.63 M (-120.28%)
What is Vir Biotechnology TTM cash flow from operations?
The current TTM CFO of VIR is -$466.64 M
What is the all time high TTM CFO for Vir Biotechnology?
Vir Biotechnology all-time high TTM cash flow from operations is $1.66 B
What is Vir Biotechnology TTM CFO year-on-year change?
Over the past year, VIR TTM cash flow from operations has changed by -$15.65 M (-3.47%)